Clinical Value of Autoantibody Prognostic Markers in Tumor Immune Checkpoint
Inhibitor Therapy / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 534-540, 2022.
Article
ي Zh
| WPRIM
| ID: wpr-939743
المكتبة المسؤولة:
WPRO
ABSTRACT
Serum autoantibody markers have the advantages of easy specimen acquisition, simple detection technology and dynamic real-time monitoring. With the wide application of immune checkpoint inhibitors in the treatment of malignant tumors, autoantibody markers in predicting tumor immune checkpoint inhibitors efficacy and forecasting irAEs (immune related adverse events) show good prediction of potential. This review mainly focused on the progress of autoantibody markers in the prediction of therapeutic effect and the monitoring of irAE in tumor immunotherapy.
.
Key words
النص الكامل:
1
الفهرس:
WPRIM
الموضوع الرئيسي:
Prognosis
/
Immune Checkpoint Inhibitors
/
Immunotherapy
/
Lung Neoplasms
/
Neoplasms
نوع الدراسة:
Prognostic_studies
المحددات:
Humans
اللغة:
Zh
مجلة:
Chinese Journal of Lung Cancer
السنة:
2022
نوع:
Article